Why Investors Shouldn't Be Surprised By Shenzhen Hepalink Pharmaceutical Group Co., Ltd.'s (SZSE:002399) Low P/S
You may think that with a price-to-sales (or "P/S") ratio of 2.8x Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SZSE:002399) is a stock worth checking out, seeing as almost half of all the Pharmac
Solid Earnings Reflect Sichuan Biokin PharmaceuticalLtd's (SHSE:688506) Strength As A Business
Sichuan Biokin Pharmaceutical Co.,Ltd.'s (SHSE:688506) strong earnings report was rewarded with a positive stock price move. Our analysis found some more factors that we think are good for shareholde
Earnings Troubles May Signal Larger Issues for Yantai Dongcheng Pharmaceutical GroupLtd (SZSE:002675) Shareholders
The market rallied behind Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s (SZSE:002675) stock, leading do a rise in the share price after its recent weak earnings report. We think that shareholders
Huapont Life SciencesLtd's (SZSE:002004) Conservative Accounting Might Explain Soft Earnings
The market was pleased with the recent earnings report from Huapont Life Sciences Co.,Ltd (SZSE:002004), despite the profit numbers being soft. However, we think the company is showing some signs tha
Additional Considerations Required While Assessing Nanning Department Store's (SHSE:600712) Strong Earnings
Nanning Department Store Co., Ltd. (SHSE:600712) just reported some strong earnings, and the market reacted accordingly with a healthy uplift in the share price. However, we think that shareholders m
Huasun Technology to Cancel 3.8 Million Repurchased Shares
Chinese drugmaker Chengdu Huasun Technology Group (SHE:000790) will cancel 3.8 million shares that the company repurchased, the company said in its filing on the Shenzhen Stock Exchange. The shares, w